Foramen oval permeable: ¿está justificado el cierre percutáneo?

Hagen, 1984, Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts, May Clin Proc, 59, 17, 10.1016/S0025-6196(12)60336-X Medrano Albero, 2006, Incidencia y prevalencia de la cardiopatía isquémica y la enfermedad cerebrovascular en España. Revisión sistemática de la literatura, Rev Esp Salud Pública, 80, 5, 10.1590/S1135-57272006000100002 Cruz-González, 2008, Foramen oval permeable: situación actual, Rev Esp Cardiol, 61, 738, 10.1157/13123995 Kutty, 2012, Patent foramen ovale. The known and the to be known, JACC, 59, 1665, 10.1016/j.jacc.2011.09.085 Furlan, 2012, Closure or medical therapy for cryptogenic stroke with patent foramen ovale, N Engl J Med, 366, 991, 10.1056/NEJMoa1009639 Lechat, 1988, Prevalence of patent foramen ovale in patients with stroke, N Engl J Med, 318, 1148, 10.1056/NEJM198805053181802 Di Tullio, 1992, Patent foramen ovale as a risk factor for cryptogenic stroke, Ann Intern Med, 117, 461, 10.7326/0003-4819-117-6-461 Steiner, 1998, Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke, Stroke, 29, 944, 10.1161/01.STR.29.5.944 Meissner, 2006, Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study, J Am Coll Cardiol, 47, 440, 10.1016/j.jacc.2005.10.044 Petty, 1997, Patent foramen ovale in patients with cerebral infarction. A transesophageal echocardiographic study, Arch Neurol, 54, 819, 10.1001/archneur.1997.00550190013008 Handke, 2007, Patent foramen ovale and cryptogenic stroke in older patients, N Engl J Med, 357, 2262, 10.1056/NEJMoa071422 Overell, 2000, Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies, Neurology, 55, 1172, 10.1212/WNL.55.8.1172 Mas, 2001, Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both, New Engl J Med, 345, 1740, 10.1056/NEJMoa011503 Di Tullio, 2007, Patent foramen ovale and the risk of ischemic stroke in a multiethnic population, J Am Coll Cardiol, 49, 797, 10.1016/j.jacc.2006.08.063 Homma, 2002, Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study, Circulation, 105, 2625, 10.1161/01.CIR.0000017498.88393.44 Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis. 1998;8:327–30. Dowson, 2008, Circulation, 117, 1397, 10.1161/CIRCULATIONAHA.107.727271 Homma, 2005, Patent foramen ovale and stroke, Circulation, 112, 1063, 10.1161/CIRCULATIONAHA.104.524371 Mohr, 2001, A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke, N Engl J Med, 345, 1444, 10.1056/NEJMoa011258 Bogousslavsky, 1996, Lausanne Stroke with Paradoxal Embolism Study Group Stroke recurrence in patients with patent foramen ovale: the Lausanne study, Neurology, 46, 1301, 10.1212/WNL.46.5.1301 Fuentes B, Gállego J, Gil-Nuñez A, et al. Guía para el tratamiento preventivo del ictus isquémico y AIT (II). Recomendaciones según subtipo etiológico. Neurología 2011. Neurologia. 2011 Sep 19. [Epub ahead of print]. http://dx.doi.org/10.1016/j.nrl.2011.06.003.